Study tips17 min read

How to study for USMLE Step 3: a 6-week plan with worked CCS cases

Understand the two-day format, follow a 6-week plan, and work through CCS cases, biostatistics and ethics with practice questions.

Medly Team20 November 2026
On this page

This guide shows you how to study for USMLE Step 3 in 6 weeks. You start with multiple-choice blocks, add Computer-based Case Simulations (CCS) from week 3, and give biostatistics and ethics most of your time in the final fortnight. Along the way it works through two CCS cases order by order, so you can see what the software rewards, and it finishes with practice questions to try.

USMLE Step 3 format: Day 1, Day 2 and the CCS cases

Step 3 takes two days at a Prometric test centre. Day 1, Foundations of Independent Practice (FIP), is all multiple-choice. Day 2, Advanced Clinical Medicine (ACM), has more multiple-choice questions, then the CCS cases. Exams with a first testing day on or after 10 March 2026 use new delivery software with shorter blocks. The number of questions and the overall length stayed the same.

PartDay 1 (FIP)Day 2 (ACM)
Multiple-choice questions232180
Blocks12 blocks of 18 to 209 blocks of 20
Time per block30 minutes30 minutes
CCS casesNone13 to 14
Time per caseNone10 or 20 minutes at most
Length of the dayAbout 7 hoursAbout 9 hours

Source: USMLE software update. Last checked: 19 November 2026.

You'll see different CCS counts quoted online. The USMLE's own software update lists 13 to 14 cases, which is the figure to plan around. You can only review questions inside the block you're in, so once you close a block, it's done. With 20 questions in 30 minutes, you have 90 seconds a question.

The minimum passing score is 200. On 5 November 2026, the USMLE announced that its Management Committee had voted to keep it at 200.

How to study for USMLE Step 3: a 6-week plan

The plan assumes you've passed Step 1 and Step 2 CK and can study for 3 to 4 hours on most days, around residency or work. Spend the first two weeks getting your multiple-choice speed back. Bring in CCS from week 3, because the software has habits you only learn by using it. Keep a short daily biostatistics set going from week 1 so the formulas stay fresh, then go deep on biostatistics and ethics in weeks 5 and 6.

WeekMain focusDaily questionsCCS cases
1Cardiology, respiratory, renal2 timed blocks of 20None
2GI, endocrine, neurology, psychiatry2 to 3 blocksNone
3Obstetrics, gynaecology, paediatrics2 blocks2 a day
4Musculoskeletal, skin, weak areas2 blocks3 a day
5Biostatistics, ethics, Day 1 practice test2 blocks plus biostatistics3 a day
6Biostatistics, ethics, Day 2 practice test1 to 2 blocks2 to 3 a day

Source: Medly's suggested plan, weighted by the Step 3 content outline. Last checked: 19 November 2026.

Each study day follows the same steps:

  1. Do your blocks timed, at 30 minutes each, in the order you'll meet them on the day.
  2. Review every question, including the ones you got right. Write down why each wrong option was wrong.
  3. From week 3, do your CCS cases after the blocks, when you're tired. That's how Day 2 feels.
  4. Log each mistake by system and by type: knowledge, reading, timing or management order.
  5. Take one day off each week. Take the day before the exam off as well.

Start CCS with the six free sample cases on the CCS page of usmle.org, which come with feedback. You can download the 6-week plan as a spreadsheet and adjust the weeks to fit your rota.

How CCS is scored, and the order of actions that earns credit

Each CCS case puts one patient in front of you. You type orders on a free-text order sheet, and the patient changes in response to the disease and to what you do. According to usmle.org:

  • Actions that are indicated earn credit.
  • Riskier actions that aren't indicated lower your score.
  • Timing and sequence matter. The right decision made late, or in the wrong order, may earn no credit.
  • Counselling, diet and activity orders usually carry little weight unless they matter to the case.
  • In low-intervention cases, you earn credit for holding back on tests and treatment.

The USMLE's scoring page says that the case simulations count towards your Step 3 score, and that their weight is no greater than the share of the exam time they take up.

This order of actions works for most cases:

  1. If the patient is unstable, treat that first: monitoring, IV access and oxygen if they're hypoxic.
  2. Order a focused examination. Each exam component costs simulated time, so only order the systems you need.
  3. Order the tests and the time-critical treatment together. Don't wait for results before giving treatment that can't wait.
  4. Advance the clock to the next result or update, and no further. Results only appear when the clock reaches their report time.
  5. Reassess, change treatment and move the patient to the right place (ward, ICU, home).
  6. Before the case ends, add prevention, counselling and follow-up. These orders are quick to type.

A case can end before its time is up. Reaching the end-of-case screen tells you nothing about whether you did well.

Worked CCS case 1: STEMI in the emergency department

Worked example (20-minute CCS case)

A 58-year-old man comes to the emergency department after 50 minutes of central chest pressure and sweating. Pulse is 96/min, blood pressure is 148/90 mm Hg and oxygen saturation is 96% on room air. The hospital has a cardiac catheterisation laboratory that can take him straight away.

Medly's Step 3 lesson on STEMI teaches the management in four steps: recognise it, stabilise him without delaying reperfusion, choose a reperfusion strategy, then reassess. In CCS, that becomes:

  1. Start of the case, before you move the clock: cardiac monitor, IV access, pulse oximetry and a 12-lead ECG. The lesson's target is an ECG within 10 minutes of first contact.
  2. Same screen: examine the general appearance, chest and lungs, heart and extremities. Look for congestion, a new murmur and signs of shock.
  3. Advance the clock only as far as the ECG result. It shows ST elevation in V1 to V4, which means an anterior STEMI.
  4. Now place all of these together: aspirin 162 to 325 mg chewed, IV heparin, a P2Y12 inhibitor such as ticagrelor, sublingual nitroglycerin for pain, and an order for cardiac catheterisation with primary PCI. Add a cardiology consult.
  5. At the same time: troponin, complete blood count, basic metabolic panel, coagulation studies, lipid panel and a portable chest X-ray. Don't wait for the troponin. A typical presentation with a diagnostic ECG is enough to start the reperfusion pathway.
  6. After PCI, move him to the coronary care unit. Start atorvastatin 80 mg and oral metoprolol (he isn't in shock or heart failure), and order an echocardiogram. Because the infarct is anterior, start an oral ACE inhibitor such as lisinopril within the first 24 hours, whatever the ejection fraction, as long as he isn't hypotensive.
  7. Before the case ends: smoking cessation counselling if he smokes, a referral to cardiac rehabilitation, and follow-up.

He has a cath lab on site, so PCI is the strategy, with a first-contact-to-device goal of 90 minutes or less. Thrombolysis is for when PCI would be more than 120 minutes away, symptoms started within 12 hours and there's no contraindication. His oxygen saturation is above 90%, so routine oxygen isn't indicated. If he'd taken sildenafil in the last 24 hours, was hypotensive, or had a right ventricular infarct, nitroglycerin would be wrong. Prasugrel is off the table for anyone with a previous stroke or TIA.

Worked CCS case 2: low back pain in the office

Worked example (10-minute CCS case)

A 41-year-old warehouse worker comes to the office with 5 days of low back pain that started after lifting boxes. He has no fever, weight loss, history of cancer, numbness in the saddle area, or change in bladder or bowel function. His vital signs are normal.

This is a low-intervention case. The credit comes from leaving things out.

  1. Examine the general appearance, back, extremities and neurological system. Straight-leg raise, reflexes, strength and sensation are all normal.
  2. Order no imaging and no blood tests. There are no red flags, and an MRI or X-ray here is a test without a reason.
  3. Treat: an oral NSAID such as ibuprofen, plus advice to use heat and stay active. Tell him to avoid bed rest.
  4. Counsel him on the red flags that should bring him back sooner: leg weakness, saddle numbness, or bladder or bowel changes.
  5. Schedule a follow-up visit, then advance the clock. With nothing pending, the case moves on to its end.

Opioids as the first treatment, a spinal MRI or a specialist referral would all add risk or cost with no benefit. On usmle.org's list of actions that lower a score, ordering invasive tests or procedures without need is one of the examples.

Biostatistics and ethics in the final fortnight

In the content outline, biostatistics, epidemiology and reading the medical literature make up 11 to 13% of Step 3's multiple-choice questions. That's the biggest single area. Communication, ethics and patient safety add another 7 to 9%. Neither area appears in the CCS cases, so a lot of these marks are on Day 1.

For the formulas, the most common Step 3 calculations are:

  • Absolute risk reduction (ARR) = control risk − treatment risk, as a proportion.
  • NNT = 1 ÷ ARR, rounded up to a whole patient.
  • Number needed to harm (NNH) = 1 ÷ absolute risk increase.
  • For a risk difference, the null value is 0. For a ratio, it's 1.

Our Step 1 biostatistics guide covers sensitivity, specificity and the rest, and the biostatistics formula sheet is a good thing to keep beside you. Step 3 adds abstracts and drug advertisements to read, so get used to pulling the numbers out of a table.

Worked example (1 mark)

This is a part of an exam-style question from Medly's Step 3 course, with the other parts left out.

The following is an illustrative research abstract.

Methods: In a randomized, double-blind trial, 1,000 adults with type 2 diabetes, albuminuria, and stage 3 chronic kidney disease were enrolled at outpatient clinics. Participants were assigned in equal numbers to the two groups. All received an angiotensin-converting enzyme inhibitor and dapagliflozin; the intervention group also received finerenone, and the control group received a matching placebo. Follow-up lasted 24 months. Hyperkalemia was defined as serum potassium greater than 5.5 mEq/L. Absolute risk differences were calculated as dual-therapy risk minus standard-care risk. The prespecified two-sided significance level was 0.05.

OutcomeDual therapy (n = 500)Standard care (n = 500)p-value
Hyperkalemia11.0% (55/500)6.0% (30/500)0.005
Symptomatic orthostatic hypotension5.0% (25/500)4.0% (20/500)0.45

A clinician evaluates the adverse outcomes using the prespecified significance level. Which interpretation of the 24-month findings is most appropriate?

A. Neither adverse outcome: significant.

B. Orthostatic hypotension: significant; number needed to harm 100.

C. Hyperkalemia: significant; number needed to harm 20.

D. Hyperkalemia: significant; number needed to harm 9, based on treated risk.

E. Hyperkalemia: significant; number needed to harm 5, based on the risk increase.

The answer is C. Here's how you get there:

  1. Check significance first. Hyperkalaemia has p = 0.005, which is below 0.05, so it's significant. Orthostatic hypotension has p = 0.45, so it isn't.
  2. Hyperkalaemia risk increase = 0.11 − 0.06 = 0.05.
  3. NNH = 1 ÷ 0.05 = 20.

A is wrong because the hyperkalaemia result is significant. B gets the arithmetic right (1 ÷ 0.01 = 100), but p = 0.45 isn't significant. D uses the treated group's risk (1 ÷ 0.11 ≈ 9) instead of the increase. E treats 5% as 5 instead of 0.05. Medly's mark scheme gives the mark for C alone.

The ethics and safety questions test judgement more than recall. Practise these themes:

  • Decision-making capacity. A patient who understands, appreciates, reasons and states a choice can refuse treatment, even when you disagree.
  • Informed consent and refusal, including who decides for a patient without capacity.
  • Confidentiality and its legal limits, such as reportable diseases and serious risk to others.
  • Telling a patient promptly and honestly about a medical error.
  • Patient safety questions, where the best answer usually changes the system (a protocol, a checklist) instead of blaming one person.
  • Explaining numbers to patients in plain words, which is how NNT often turns up.

USMLE Step 3 practice questions

Questions 1 to 4 come from Medly's Step 3 course and practice papers. They're Medly's own questions, not past paper questions. Question 5 is a CCS case to plan on paper before you open the answer.

Question 1: (1 mark)

A 61-year-old man comes to the emergency department 45 minutes after the onset of persistent central chest pressure and nausea. He has hypertension. Pulse is 92/min and blood pressure is 136/82 mm Hg. Oxygen saturation is 97% on room air. A 12-lead ECG shows 3 mm of ST-segment elevation in leads V2 through V4 and ST-segment depression in leads II, III, and aVF. He receives aspirin. The initial cardiac troponin result is pending. The hospital has an immediately available cardiac catheterization laboratory.

Which of the following is the most appropriate next step?

A. Transesophageal echocardiography to exclude aortic dissection

B. Coronary CT angiography before catheterization

C. Rest-stress myocardial perfusion scintigraphy

D. Serial troponin measurements before determining reperfusion candidacy

E. Immediate coronary angiography and reperfusion assessment

Answer
  1. His symptoms and the ST elevation in V2 to V4 (with reciprocal inferior depression) show an acute STEMI.
  2. A cath lab is available now, so the next step is E, immediate coronary angiography and reperfusion assessment.
  3. D is wrong because troponin shouldn't delay reperfusion once the ECG confirms STEMI. Nothing here suggests aortic dissection (A). CT angiography (B) and stress testing (C) would delay reperfusion, and stress testing is inappropriate during an acute STEMI.

The trap here is choosing to wait for troponin.

Question 2: (1 mark)

A hospital quality-improvement audit examines care for patients with ST-elevation myocardial infarction who undergo primary percutaneous coronary intervention. The median door-to-balloon time is 118 minutes, and in-hospital mortality has increased compared with the previous audit period. When an initial ECG shows ST-segment elevation, the emergency physician completes intravenous medication titration, portable chest radiography, and arterial blood gas sampling before paging the on-call cardiology fellow. The fellow then examines the patient in person before activating the catheterization team. Pretransfer safety checks include assessment of vital signs and airway status, establishment of intravenous access, and cardiac monitoring.

Which of the following organizational interventions is most likely to accelerate reperfusion while limiting inappropriate catheterization laboratory activations and preserving essential pretransfer safety checks?

A. Require two cardiology attendings to review transmitted ECGs and complete electronic risk scores before the catheterization team is paged.

B. Authorize physician single-call activation after ECG confirmation, with a parallel pretransfer stabilization checklist.

C. Send quarterly newsletters to emergency department and cardiology staff emphasizing the mortality benefit of door-to-balloon times under 90 minutes.

D. Require completion of intravenous beta-blocker infusions, radiography, and laboratory panels within 20 minutes before contacting the cardiology fellow.

E. Permit triage technicians to activate the catheterization team using automated ECG alerts before physician review or vital-sign assessment.

Answer
  1. The delay comes from steps done one after another before anyone activates the team.
  2. B fixes that: a physician confirms the ECG and activates with one call, and the safety checklist runs alongside.
  3. A adds more reviews, so activation is slower. C is education alone and doesn't change the process. D keeps the steps in sequence, and beta-blockers aren't right for every patient. E skips clinical checks, which risks false activations and missed instability.

Question 3: (1 mark)

A 64-year-old man attends an outpatient cardiac rehabilitation program for follow-up of heart failure with reduced ejection fraction. He reports fatigue when climbing stairs, without recent worsening, chest pain, or syncope. He was hospitalized for heart failure 8 months ago and has completed supervised exercise rehabilitation. He takes guideline-directed heart-failure therapy as prescribed. He does not smoke or drink alcohol. His body mass index is 27 kg/m². Temperature is 36.8°C, pulse is 72/min, respirations are 15/min, and blood pressure is 118/74 mm Hg. Oxygen saturation is 97% on room air. Examination shows no jugular venous distention or peripheral edema. His most recent left ventricular ejection fraction was 30%. He asks about an additional therapy. In a randomized trial, 65 of 500 patients assigned the therapy and 90 of 500 assigned placebo were hospitalized for heart failure during 1 year; all participants received usual care and completed follow-up.

What is the number of patients who must receive the additional therapy for 1 year to prevent one additional hospitalization for heart failure?

A. 5

B. 10

C. 20

D. 25

E. 40

Answer
  1. Placebo risk = 90 ÷ 500 = 0.18.
  2. Therapy risk = 65 ÷ 500 = 0.13.
  3. ARR = 0.18 − 0.13 = 0.05.
  4. NNT = 1 ÷ 0.05 = 20. The answer is C.

A reads the 5-percentage-point ARR as 5 patients. D is the difference in event counts (90 − 65). E divides 25 by all 1,000 participants instead of 500 in each group.

Question 4: (1 mark)

A 64-year-old man with chronic heart failure and an ejection fraction of 35% comes to the office for follow-up. He is considering adding a sodium-glucose cotransporter 2 inhibitor to his regimen. His vital signs are within normal limits, and examination shows no jugular venous distention or lower limb edema. A clinic handout states that, for patients with his condition, the number needed to treat with this medication is 20 over 2 years to prevent a heart failure hospitalization. He says, "Must I take this for 20 years before it prevents a fatal heart attack?"

Which of the following is the most appropriate response by the physician?

A. "The number means you would need to take the medication for 20 years to prevent a heart failure hospitalization or a fatal heart attack."

B. "Clinical guidelines recommend this medication for your condition, so I recommend that you start taking it now."

C. "I understand. Treating 20 similar patients for 2 years prevents one additional heart failure hospitalization versus no treatment; fatal heart attacks are not specified."

D. "I understand your concern. Does this mean 19 of 20 people get no benefit from this medication for any outcome?"

E. "The number means that 20% of patients who take the medication for 2 years will avoid a heart failure hospitalization or a fatal heart attack."

Answer
  1. NNT counts patients, not years, and it applies to one stated outcome over one stated period.
  2. C acknowledges his worry and explains the number correctly: 20 patients, 2 years, heart failure hospitalisation.
  3. A confuses patients with years. B ignores his question. D suggests NNT tells you which people benefit. E is wrong because an NNT of 20 means a 5% absolute reduction, not 20%.

Question 5: (CCS case, 20 minutes)

A 24-year-old woman with type 1 diabetes comes to the emergency department after 2 days of vomiting and abdominal pain. She has missed several insulin doses. Pulse is 118/min, blood pressure is 98/60 mm Hg and respirations are 28/min and deep. Fingerstick glucose is 480 mg/dL. Plan your orders in sequence, and say when you would advance the clock and where she should be managed.

Answer
  1. Before moving the clock: cardiac monitor, IV access, pulse oximetry, and a focused exam (general appearance, chest, heart, abdomen, neurological).
  2. Same screen: basic metabolic panel, venous or arterial blood gas, serum ketones, urinalysis, complete blood count, ECG and a pregnancy test.
  3. Start IV 0.9% saline straight away. She is tachycardic and hypotensive, so fluids can't wait for results.
  4. Advance the clock to the potassium result. Start an IV insulin infusion only once potassium is known not to be low. If it is low, replace potassium first and hold the insulin.
  5. Move her to the ICU for the insulin infusion.
  6. Check glucose every hour and electrolytes every 2 to 4 hours, adding potassium to the fluids to keep it in range. Add dextrose to the fluids as glucose falls, and keep the insulin going until the ketoacidosis resolves.
  7. Look for the trigger: missed insulin here, but also check for infection.
  8. Once she's eating and the acidosis has resolved, start subcutaneous basal insulin and overlap it with the infusion before stopping. Finish with diabetes education and follow-up.

The usual mistakes are starting insulin before checking potassium, or leaving her on the ward. The 2024 consensus report on hyperglycaemic crises has the full thresholds.

Medly's USMLE Step 3 course has more questions like these, with lessons on topics such as STEMI and number needed to treat, and full practice papers set out in exam-style blocks. Each question comes with an explanation of why the right answer is right and why every other option is wrong.

Frequently asked questions

How many CCS cases are on USMLE Step 3?

The USMLE lists 13 to 14 CCS cases on Day 2, each with a maximum of 10 or 20 minutes. This didn't change when the new software arrived in March 2026.

Is 6 weeks enough to study for Step 3?

Yes, for most candidates who passed Step 2 CK recently. If your Step 2 CK was a while ago, or you're working long shifts, add 2 to 4 weeks. Our Step 2 CK plan shows how a longer schedule fits together.

What is the passing score for USMLE Step 3?

The minimum passing score for Step 3 is 200. On 5 November 2026, the USMLE announced that it would stay at that level. On the multiple-choice questions, the USMLE says examinees typically need about 60% correct, and the exact figure changes from form to form.

Do the CCS cases count towards the Step 3 score?

Yes. According to usmle.org, case simulations can affect your score and whether you pass, and their weight is no greater than their share of the exam time.

Is biostatistics high yield on Step 3?

Yes. Biostatistics, epidemiology and reading the medical literature make up 11 to 13% of the multiple-choice questions. That's the largest single area in the content outline.

Can you go back to an earlier block on Step 3?

No. You can review questions inside the block you're in, but once you close a block you can't go back to it.

Try Medly for free